Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shu Chin Ma"'
Autor:
Jagdeep T. Podichetty, Sakshi Sardar, Nick Henscheid, Grace V. Lee, J. Rubin Abrams, Wes Anderson, Shu Chin Ma, Klaus Romero
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 6, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/c3070bfc75f94259a987244ea04caf75
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 4, Pp 1027-1035 (2022)
Abstract Hereditary angioedema (HAE) is an autosomal dominant disorder characterized by recurrent episodes of swelling of the skin, larynx, gastrointestinal tract, genitals, and extremities that can be disruptive to patient quality of life. Dysregula
Externí odkaz:
https://doaj.org/article/2ba5cc49c00040868fba32a81ee90dca
Autor:
Michelle L. Green, Shu Chin Ma, Sandra Goble, Heidi Giordano, Lara Maloney, Andrew D. Simmons, Jeri Beltman, Thomas C. Harding, Jim J. Xiao
Publikováno v:
Cancer Chemotherapy and Pharmacology. 89:671-682
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65386d67b0bf588fee0fdff95b3c05dd
https://doi.org/10.1007/s00280-022-04413-7
https://doi.org/10.1007/s00280-022-04413-7
Publikováno v:
Clinical and translational science. 15(4)
Hereditary angioedema (HAE) is an autosomal dominant disorder characterized by recurrent episodes of swelling of the skin, larynx, gastrointestinal tract, genitals, and extremities that can be disruptive to patient quality of life. Dysregulation of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42c46093d7e21b41bce436430b22cca1
https://pubmed.ncbi.nlm.nih.gov/35212456
https://pubmed.ncbi.nlm.nih.gov/35212456
Autor:
Michelle L, Green, Shu Chin, Ma, Sandra, Goble, Heidi, Giordano, Lara, Maloney, Andrew D, Simmons, Jeri, Beltman, Thomas C, Harding, Jim J, Xiao
Publikováno v:
Cancer chemotherapy and pharmacology. 89(5)
To develop a population pharmacokinetics (PPK) model for rucaparib, an oral poly(ADP-ribose) polymerase inhibitor.The PPK analysis used PK data from patients in Study 1014 (NCT01009190, n = 35), Study 10 (NCT01482715, n = 123), and ARIEL2 (NCT0189134
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::82e4fa8c7ba94fdcc5e3f80cf267eb83
https://pubmed.ncbi.nlm.nih.gov/35397664
https://pubmed.ncbi.nlm.nih.gov/35397664
Publikováno v:
Blood. 134:5766-5766
Introduction KRT-232 is a potent and selective, targeted small molecule inhibitor of human mouse double minute 2 (MDM2) homolog interactions with tumor protein 53 (p53). MDM2 prevents p53 activation and reduces p53-mediated transcription and cell cyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c3d97ce4381c007524477fa952ac829
https://doi.org/10.1182/blood-2019-131331
https://doi.org/10.1182/blood-2019-131331
Autor:
Shu Chin Ma, Rebecca M. Williams, Mark Stroh, Warren R. Zipfel, W. Mark Saltzman, Watt W. Webb
Publikováno v:
Nature materials. 3(7)
Brain-derived neurotrophic factor (BDNF) is a promising therapeutic agent for the treatment of neurodegenerative diseases. However, the limited distribution of this molecule after administration into the brain tissue considerably hampers its efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56594e241945d18a6a795ef9c16be7a6
https://pubmed.ncbi.nlm.nih.gov/16195756
https://pubmed.ncbi.nlm.nih.gov/16195756